For information about COVID-19 testing and care, vaccination, and visitor guidelines at Duke please visit

Duke-Industry Statistics Symposium (4.21 to 4.23.21)


This year's Duke-Industry Statistics Symposium (DISS) — Emerging Clinical Initiatives in Pharmaceutical Development: Methodology and Regulatory Perspectives — will be held via Zoom April 21 to April 23. The symposium includes short courses, keynotes, parallel sessions, a poster session and a job fair.

Organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine and co-sponsored by Amgen, ASA-NC Chapter, Boehringer-Ingelheim, Genentech, ICSA, IQVIA, Janssen, Journal of Biopharmaceutical Statistics, Lilly, Merck, Otsuka, Parexel, PPD, SAS, UCB and ViiV, the annual symposium was established seven years ago to discuss challenging issues and recent advances related to the clinical development of drugs, biologics and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.

Mustafa Khasraw, MD, will be a featured speaker at thursday's (April 22) Clinical Experience for Cancer Immunotherapy Trial Design session on design issues in immunotherapy trials with a biologic primary endpoints. Khasraw is deputy director of the Center for Cancer Immunotherapy at Duke Cancer Institute.



Short Course Fees: $300 for each half-day course.

Registration Fee for Symposium: $300* with all events in one fee

*The symposium is free for all graduate students or postdoctoral scholars with major in statistics, biostatistics, or bioinformatics. Please contact Dr. Anna Maria Masci at to provide proof for your identity and receive a promo code for complimentary registration to the symposium.

*Group discount for registration fee is available for those with more than 10 registrations of a single institution. Contact Sharon Updike at for more information.

*Promo codes for Executive and Organizing Committees members, short course instructors, invited speakers and discussants are available. Contact Sharon Updike at for more information.